CRDL Cardiol Therapeutics Inc.

$2.15 -0.23%

Updated 16 d ago

Healthcare · Biological Products, (No Diagnostic Substances)

Cardiol Therapeutics Inc. (CRDL) is a healthcare company in the Biological Products, (No Diagnostic Substances) industry. Shares last traded at $2.15, 5.1% below their 52-week high. Over the past year the stock is up 96.8%.

Market Cap

—

Shares Out

—

EPS (TTM)

—

P/E Ratio

—

P/S Ratio

—

P/B Ratio

—

Dividend / Share

—

Dividend Yield

—

52-Week High

$2.27

52-Week Low

$0.88

Volume

66,004

Avg Vol (3m)

52,373.889

Performance

+4.61%

+60.22%

+85.78%

+114.43%

YTD

+117.35%

+96.80%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

72.19

SMA (50)

$1.44

SMA (200)

$1.20

Price vs SMA50

+49.85%

Price vs SMA200

+79.60%

ATR (14)

$0.13

Full technical analysis (26 indicators, D/W/M) →

Biological Products, (No Diagnostic Substances) peers

CRDL vs 14 industry peers (Biological Products, (No Diagnostic Substances)), by market cap. Updated 16 d ago

1–14 of 14


AMGN	Amgen	$240.1B	27.47	6.30	23.0%	+0.31%
GILD	Gilead Sciences	$187.5B	-57.87	6.16	-10.6%	+1.09%
MRNA	Moderna	$58.8B	-18.68	—	—	-1.94%
RVMD	Revolution Medicines, Inc.	$45.2B	-25.55	—	—	+0.76%
BIIB	Biogen	$33.1B	24.16	3.34	13.8%	+0.78%
NBIX	Neurocrine Biosciences Inc	$16.1B	22.81	4.77	20.9%	+0.33%
EXEL	Exelixis, Inc.	$14.7B	17.03	6.02	35.3%	+1.00%
HALO	Halozyme Therapeutics, Inc.	$12.6B	30.39	7.55	24.9%	+1.01%
TECH	Bio-Techne	$11.4B	62.48	9.35	15.0%	+0.21%
KRYS	Krystal Biotech, Inc.	$11.0B	45.52	24.95	54.8%	+0.58%
APGE	Apogee Therapeutics, Inc.	$10.2B	-34.57	—	—	+0.04%
KYMR	Kymera Therapeutics, Inc.	$9.7B	-32.51	—	—	-1.24%
RGEN	Repligen Corp	$9.6B	230.53	12.20	5.3%	-1.87%
PCVX	Vaxcyte, Inc.	$9.1B	-8.56	—	—	-0.62%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.